IBD Research Resource Center

Clinical ID	c3156
Identifier	JPRN-jRCT1092220114
Trial Title	A study of total gastrointestinal screening by a single capsule endoscopy with magnetic navigation - MAGNAVICE
Trial URL	Visit Original Page

Study Results	No results available
Conditions	Gastrointestinal Malignant Tumor, Gastric or Duodenal Ulcer, Gastrointestinal Bleeding,_Gastrointestinal Benign Tumor, Inflammatory Bowel Disease, Gastrointestinal screening
Interventions	Intervention type:DEVICE Name of intervention:Comparative study between capsule endoscopy and conventional endoscopy on the accuracy and acceptability of gastrointestinal screening Dose form / Japanese Medical Device Nomenclature:DEVICE Capsule endoscopy Route of administration / Site of application:ORAL Dose per administration:1 1 1/unit Dosing frequency / Frequency of use:ONCE ONCE/Examination Planned duration of intervention:8 hours (after ingesting a capsule endoscope) Intended dose regimen:Preparation before and after(booster) ingesting a capsule endoscope, Lubiprostone intake after passing stomach detailes of teratment arms:Volunteers or digestive disease patients who underwent or will undergo upper and lower conventional endoscopy before or after a capsule endoscopy Comparative intervention name:Conventional endoscopic findings before or after capsule endoscopy Dose form / Japanese Medical Device Nomenclature:DEVICE Capsule endoscopy Route of administration / Site of application:ORAL Dose per administration:1 1 1/unit Dosing frequency / Frequency of use:ONCE ONCE Planned duration of intervention:Eight hours after ingesting a capsule endoscope Intended dose regimen:Preparation before and after(booster) ingesting a capsule endoscope

Sex Requirement	ALL
Age Requirement	-

Study Type	Interventional
Phase	Not Available